Nadine Kutsch
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: March 17, 2026
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 05, 2026
Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry.
Journal: European journal of haematology
Published: December 12, 2025
Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.
Journal: Blood advances
Published: September 20, 2024
End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 30, 2024
The role of trephine bone marrow biopsies in the era of measurable residual disease-Results from the CLL10 trial of the German CLL Study Group (GCLLSG).
Journal: HemaSphere
Published: May 14, 2024
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapy.
Journal: British journal of haematology
Published: March 15, 2024
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.
Journal: European journal of haematology
Published: January 15, 2024
Last Updated: 09/26/2026